Assessing the risk of heart disease in women with polycystic ovary syndrome

Phase 3

Recruiting

• Conditions: Polycystic ovary syndrome; Cardiovascular risk; Metabolic and Endocrine - Metabolic disorders; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12610000202066
• Lead Sponsor: Cardiology Unit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Women with previously diagnosed polycystic ovary syndrome

Exclusion Criteria

Already on metformin or oral contraceptives
On clopidogrel

Study & Design

• Study Type: Interventional
• Study Design: Not specified